Abstract
Falling productivity and patent expiries are placing increasing pressure on
pharmaceutical companies to reduce fix costs including large manufacturing
facilities. Sponsors are turning to CMOs in search of time and cost savings
and as a way to flexibly manage outsourced manufacturing. Meanwhile the threat
of overcapacity combined with inevitable program cancellations following
mega-mergers resist the market. The CMO Market Outlook analyzes the market
dynamics, drivers and resistors and assesses the structure of the market.
China and India are discussed as destinations for outsourced manufacturing
including analyses of regulatory changes and patent protection. Industry
strategies are detailed and critically examined. Key players in the global,
Chinese and Indian markets are also assessed. The industry trends are examined
and used to map out the future of the industry including the impact on the
landscape of players.
| 
View Cart
